Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
about
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics.Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b.STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.Inhibition of STAT5A promotes osteogenesis by DLX5 regulation
P2860
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@ast
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@en
type
label
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@ast
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@en
prefLabel
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@ast
Structure-Based Screen Identif ...... and Chronic Myeloid Leukemia.
@en
P2093
P2860
P1476
Structure-Based Screen Identif ...... r and Chronic Myeloid Leukemia
@en
P2093
Adam Ertel
Ayush Dagvadorj
Benjamin Leiby
Bruno Calabretta
Costas D Lallas
David T Hoang
Edouard Trabulsi
Elyse Ellsworth
Gino Cingolani
Guanjun Xia
P2860
P304
P356
10.1158/1535-7163.MCT-14-0883
P577
2015-05-29T00:00:00Z